Teniposide Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Teniposide Manufacturers of Teniposide Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Teniposide's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 50 to 165 mg/m2110 (107.5)24 hourlyIVInitially for 5 days then twice weekly as a 30-60 minutes infusion solution of upto 1mg/ml in NaCl 0.9% or D5W. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Teniposide is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Teniposide is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Teniposide Back to top Manufacturers of Teniposide in Pakistan Back to top Previous Drug Generic - Next Drug Generic
Teniposide Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Teniposide Manufacturers of Teniposide Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Teniposide's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 50 to 165 mg/m2110 (107.5)24 hourlyIVInitially for 5 days then twice weekly as a 30-60 minutes infusion solution of upto 1mg/ml in NaCl 0.9% or D5W. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Teniposide is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Teniposide is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Teniposide Back to top Manufacturers of Teniposide in Pakistan Back to top Previous Drug Generic - Next Drug Generic